|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Cash flows from operating activities: | |
| Net loss | |
| Adjustments to reconcile net loss to net cash used in operating activities: | |
| Depreciation and amortization | |
| Stock-based compensation expense | |
| Amortization of debt discount and debt issuance costs | |
| Amortization of right-of-use asset | |
| Accretion of discounts on investments, net | |
| Change in fair value of common stock warrant liability | |
| Loss on extinguishment of debt | |
| Non-cash interest charges | |
| Change in allowance for credit losses | |
| Changes in assets and liabilities: | |
| Accounts receivable, net | |
| Prepaid expenses and other current assets | |
| Other non-current assets | |
| Accounts payable | |
| Accrued expenses and other current liabilities | |
| Operating lease liabilities | |
| Other non-current liabilities | |
| Net cash used in operating activities | |
| Cash flows from investing activities: | |
| Purchase of property and equipment | |
| Purchases of investments | |
| Net cash used in investing activities | |
| Cash flows from financing activities: | |
| Proceeds from initial public offering, net of issuance costs | |
| Proceeds from convertible notes offering, net of issuance costs | |
| Proceeds from exercise of stock options | |
| Repayment of term loan | |
| Payments of exit, prepayment penalty and lender fees | |
| Payment of taxes related to vested restricted stock units | |
| Net cash provided by financing activities | |
| Effect of foreign exchange rates | |
| Net increase (decrease) in cash and cash equivalents | |
| Balance, beginning of period | |
| Balance, end of period | |
| Supplemental disclosure of cash flow information: | |
| Cash paid for interest | |
| Supplemental disclosure of non-cash investing and financing activities: | |
| Purchases of property and equipment included in accounts payable | |
| Right-of-use asset obtained in exchange for lease obligation | |
| Conversion of redeemable convertible preferred stock to common stock upon IPO | |
| Conversion of convertible notes to common stock upon IPO | |
| Conversion of term loan principal to convertible notes | |
| Reclassification of warrant liability to common stock upon net exercise | |
| Issuance of convertible notes to certain employees in lieu of cash compensation | |
| Reclassification of term loan debt discount to convertible notes debt discount |
Loading...
